WAGR Syndrome Overview
Learn About WAGR Syndrome
WAGR syndrome is a disorder that affects many body systems and is named for its main features: Wilms tumor, aniridia, genitourinary anomalies, and a range of developmental delays.
WAGR syndrome is caused by a deletion of genetic material on the short (p) arm of chromosome 11. The size of the deletion varies among affected individuals.
The prevalence of WAGR syndrome ranges from 1 in 500,000 to 1 million individuals. It is estimated that one-third of people with aniridia actually have WAGR syndrome. Approximately 7 in 1,000 cases of Wilms tumor can be attributed to WAGR syndrome.
Most cases of WAGR syndrome are not inherited. They are caused by a chromosomal deletion that occurs randomly during the formation of reproductive cells (eggs or sperm) or in early fetal development. Affected people typically have no history of the disorder in their family.
Joan Han is a Pediatric Endocrinologist in Memphis, Tennessee. Dr. Han is rated as an Elite provider by MediFind in the treatment of WAGR Syndrome. Her top areas of expertise are WAGR Syndrome, Alstrom Syndrome, Obesity, and Bardet-Biedl Syndrome.
Tatyana Vasilyeva practices in Moscow, Russian Federation. Ms. Vasilyeva is rated as an Elite expert by MediFind in the treatment of WAGR Syndrome. Her top areas of expertise are WAGR Syndrome, Aniridia, Wilms Tumor, and Seckel Syndrome.
Andrey Marakhonov practices in Moscow, Russian Federation. Mr. Marakhonov is rated as an Elite expert by MediFind in the treatment of WAGR Syndrome. His top areas of expertise are Aniridia, WAGR Syndrome, Seckel Syndrome, and Infantile Neutropenia.
Summary: CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, in...
Summary: Purpose: Conduct a wait-list randomized controlled trial (RCT) of an inclusive physical activity program called PACE for adults with intellectual disability (ID) who are not yet showing signs of Alzheimer's Disease (AD)/age-related dementias (ARD). Participants: Participants include 120 adults with ID, their caregivers, and their coaches (up to 360 individual participants, grouped as triads), recr...
Published Date: June 28, 2023
Published By: National Institutes of Health